SSKN — STRATA Skin Sciences Cashflow Statement
0.000.00%
Last trade - 00:00- $8.48m
- $16.71m
- $33.56m
Annual cashflow statement for STRATA Skin Sciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | C2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -4.41 | -2.71 | -5.55 | -10.8 | -10.1 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 2.07 | 0.142 | 2.18 | 4.95 | 4.8 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.596 | 0.324 | -2.88 | -0.069 | 0.688 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 2.1 | 1.51 | -0.924 | -0.519 | 0.188 |
| Capital Expenditures | -2.16 | -3.65 | -3.74 | -5.02 | -1.64 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | -3.47 | -0.631 | 0 | — |
| Acquisition of Business | |||||
| Cash from Investing Activities | -2.16 | -7.13 | -4.37 | -5.02 | -1.64 |
| Financing Cash Flow Items | — | -0.133 | -0.5 | -0.139 | -0.018 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2.55 | 0.092 | -0.5 | 6.86 | 1.93 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 2.48 | -5.53 | -5.79 | 1.32 | 0.477 |